These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1739877)
21. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073 [TBL] [Abstract][Full Text] [Related]
22. Recombinant human bone morphogenetic protein-2 stimulates differentiation in primary cultures of fetal rat calvarial osteoblasts. Chaudhari A; Ron E; Rethman MP Mol Cell Biochem; 1997 Feb; 167(1-2):31-9. PubMed ID: 9059979 [TBL] [Abstract][Full Text] [Related]
23. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. Long MW; Robinson JA; Ashcraft EA; Mann KG J Clin Invest; 1995 Feb; 95(2):881-7. PubMed ID: 7860771 [TBL] [Abstract][Full Text] [Related]
24. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria. de Pollak C; Arnaud E; Renier D; Marie PJ J Cell Biochem; 1997 Jan; 64(1):128-39. PubMed ID: 9015761 [TBL] [Abstract][Full Text] [Related]
25. 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells. Kassem M; Mosekilde L; Eriksen EF J Bone Miner Res; 1993 Dec; 8(12):1453-8. PubMed ID: 8304046 [TBL] [Abstract][Full Text] [Related]
26. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. Yamaguchi A; Katagiri T; Ikeda T; Wozney JM; Rosen V; Wang EA; Kahn AJ; Suda T; Yoshiki S J Cell Biol; 1991 May; 113(3):681-7. PubMed ID: 1849907 [TBL] [Abstract][Full Text] [Related]
27. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Barbara A; Delannoy P; Denis BG; Marie PJ Metabolism; 2004 Apr; 53(4):532-7. PubMed ID: 15045704 [TBL] [Abstract][Full Text] [Related]
28. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization. Brandao-Burch A; Utting JC; Orriss IR; Arnett TR Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362 [TBL] [Abstract][Full Text] [Related]
29. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses. Chen TL; Hauschka PV; Cabrales S; Feldman D Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737 [TBL] [Abstract][Full Text] [Related]
30. Actions of calcipotriol (MC 903), a novel vitamin D3 analog, on human bone-derived cells: comparison with 1,25-dihydroxyvitamin D3. Evans DB; Thavarajah M; Binderup L; Kanis JA J Bone Miner Res; 1991 Dec; 6(12):1307-15. PubMed ID: 1792941 [TBL] [Abstract][Full Text] [Related]
31. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line. Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560 [TBL] [Abstract][Full Text] [Related]
32. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. Aronow MA; Gerstenfeld LC; Owen TA; Tassinari MS; Stein GS; Lian JB J Cell Physiol; 1990 May; 143(2):213-21. PubMed ID: 2332447 [TBL] [Abstract][Full Text] [Related]
33. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Kassem M; Kveiborg M; Eriksen EF Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903 [TBL] [Abstract][Full Text] [Related]
34. Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone. Bodine PV; Vernon SK; Komm BS Endocrinology; 1996 Nov; 137(11):4592-604. PubMed ID: 8895322 [TBL] [Abstract][Full Text] [Related]
35. Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children and children with abnormalities in skeletal development. Silve C; Grosse B; Tau C; Garabedian M; Fritsch J; Delmas PD; Cournot-Witmer G; Balsan S J Clin Endocrinol Metab; 1986 Mar; 62(3):583-90. PubMed ID: 3003145 [TBL] [Abstract][Full Text] [Related]
36. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687 [TBL] [Abstract][Full Text] [Related]
37. Changes in cytoskeletal proteins in response to parathyroid hormone and 1,25-dihydroxyvitamin D in human osteoblastic cells. Lomri A; Marie PJ Bone Miner; 1990 Jul; 10(1):1-12. PubMed ID: 2168775 [TBL] [Abstract][Full Text] [Related]
38. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742 [TBL] [Abstract][Full Text] [Related]
39. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. Nuttall ME; Patton AJ; Olivera DL; Nadeau DP; Gowen M J Bone Miner Res; 1998 Mar; 13(3):371-82. PubMed ID: 9525337 [TBL] [Abstract][Full Text] [Related]
40. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Bonewald LF; Harris SE; Rosser J; Dallas MR; Dallas SL; Camacho NP; Boyan B; Boskey A Calcif Tissue Int; 2003 May; 72(5):537-47. PubMed ID: 12724828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]